SEARCH

SEARCH BY CITATION

References

  • Albers GW, Goldberg MP & Choi DW (1989). N-Methyl-d-aspartate antagonists: ready for clinical trial in brain ischemia? Ann Neurol 25, 398403.
  • Andine P, Widermark N, Axelsson R, Nyberg G, Olofsson U, Martensson E & Sandberg M (1999). Characterization of MK-801-induced behavior as a putative rat model of psychosis. J Pharmacol Exp Ther 290, 13931408.
  • Antonov SM, Gmiro VE & Johnson JW (1998). Binding sites for permeant ions in the channel of NMDA receptors and their effects on channel block. Nat Neurosci 1, 451461.
  • Antonov SM & Johnson JW (1999). Permeant ion regulation of N-methyl-d-aspartate receptor channel block by Mg2+. Proc Natl Acad Sci U S A 96, 1457114576.
  • Balster RL (1991). Drug abuse potential evaluation in animals. Br J Addict 86, 15491558.
  • Balster RL & Willetts J (1988). Receptor mediation of the discriminative stimulus properties of phencyclidine and σ-opioid agonists. Psychopharmacol Ser 4, 122135.
  • Banke TG, Dravid SM & Traynelis SF (2005). Protons trap NR1/NR2B NMDA receptors in a nonconducting state. J Neurosci 25, 4251.
  • Baselt RC (2004). Disposition of Toxic Drugs and Chemicals in Man, 7th edn. Biomedical Publications, Foster City , CA , USA .
  • Benveniste M & Mayer ML (1992). Effect of extracellular pH on the potency of N-methyl-d-aspartic acid receptor competitive antagonists. Mol Pharmacol 42, 679686.
  • Blanpied TA, Boeckman FA, Aizenman E & Johnson JW (1997). Trapping channel block of NMDA-activated responses by amantadine and memantine. J Neurophysiol 77, 309323.
  • Blanpied TA, Clarke RJ & Johnson JW (2005). Amantadine inhibits NMDA receptors by accelerating channel closure during channel block. J Neurosci 25, 33123322.
  • Bolshakov KV, Gmiro VE, Tikhonov DB & Magazanik LG (2003). Determinants of trapping block of N-methyl-d-aspartate receptor channels. J Neurochem 87, 5665.
  • Bormann J (1989). Memantine is a potent blocker of N-methyl-d-aspartate (NMDA) receptor channels. Eur J Pharmacol 166, 591592.
  • Casadio R & Melandri BA (1977). The behavior of 9-aminoacridine as an indicator of transmembrane pH difference in liposomes of natural bacterial phospholipids. J Bioenerg Biomembr 9, 1729.
  • Chesler M & Kaila K (1992). Modulation of pH by neuronal activity. Trends Neurosci 15, 396402.
  • Choi DW (1985). Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci Lett 58, 293297.
  • Choi DW (1992). Excitotoxic cell death. J Neurobiol 23, 12611276.
  • Choi YB & Lipton SA (1999). Identification and mechanism of action of two histidine residues underlying high-affinity Zn2+ inhibition of the NMDA receptor. Neuron 23, 171180.
  • Church J, Zeman S & Lodge D (1988). The neuroprotective action of ketamine and MK-801 after transient cerebral ischemia in rats. Anesthesiology 69, 702709.
  • Clarke RJ & Johnson JW (2006). NMDA receptor NR2 subunit dependence of the slow component of magnesium unblock. J Neurosci 26, 58255834.
  • Costa AC & Albuquerque EX (1994). Dynamics of the actions of tetrahydro-9-aminoacridine and 9-aminoacridine on glutamatergic currents: concentration-jump studies in cultured rat hippocampal neurons. J Pharmacol Exp Ther 268, 503514.
  • Dilmore JG & Johnson JW (1998). Open channel block and alteration of N-methyl-d-aspartic acid receptor gating by an analog of phencyclidine. Biophys J 75, 18011816.
  • Dingledine R, Borges K, Bowie D & Traynelis SF (1999). The glutamate receptor ion channels. Pharmacol Rev 51, 761.
  • Dirnagl U, Iadecola C & Moskowitz MA (1999). Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22, 391397.
  • Dravid SM, Baden DG & Murray TF (2004). Brevetoxin activation of voltage-gated sodium channels regulates Ca dynamics and ERK1/2 phosphorylation in murine neocortical neurons. J Neurochem 89, 739749.
  • Ellison G (1995). The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioural and anatomical models of the dementias. Brain Res Brain Res Rev 20, 250267.
  • Erdo SL & Schafer M (1991). Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and N-methyl-d-aspartate. Eur J Pharmacol 198, 215217.
  • Erreger K, Chen PE, Wyllie DJ & Traynelis SF (2004). Glutamate receptor gating. Crit Rev Neurobiol 16, 187224.
  • Erreger K, Dravid SM, Banke TG, Wyllie DJ & Traynelis SF (2005a). Subunit-specific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signalling profiles. J Physiol 563, 345358.
  • Erreger K, Geballe MT, Dravid SM, Snyder JP, Wyllie DJ & Traynelis SF (2005b). Mechanism of partial agonism at NMDA receptors for a conformationally restricted glutamate analog. J Neurosci 25, 78587866.
  • France CP, Moerschbaecher JM & Woods JH (1991). MK-801 and related compounds in monkeys: discriminative stimulus effects and effects on a conditional discrimination. J Pharmacol Exp Ther 257, 727734.
  • Freudenthaler S, Meineke I, Schreeb KH, Boakye E, Gundert-Remy U & Gleiter CH (1998). Influence of urine pH and urinary flow on the renal excretion of memantine. Br J Clin Pharmacol 46, 541546.
  • Genovese RF & Lu XC (1991). Effects of MK-801 stereoisomers on schedule-controlled behavior in rats. Psychopharmacology (Berl) 105, 477480.
  • Geter-Douglass B & Witkin JM (1997). Dizocilpine-like discriminative stimulus effects of competitive NMDA receptor antagonists in mice. Psychopharmacology (Berl) 133, 4350.
  • Giffard RG, Monyer H, Christine CW & Choi DW (1990). Acidosis reduces NMDA receptor activation, glutamate neurotoxicity, and oxygen-glucose deprivation neuronal injury in cortical cultures. Brain Res 506, 339342.
  • Gill R, Foster AC & Woodruff GN (1987). Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil. J Neurosci 7, 33433349.
  • Halliwell RF, Peters JA & Lambert JJ (1989). The mechanism of action and pharmacological specificity of the anticonvulsant NMDA antagonist MK-801: a voltage clamp study on neuronal cells in culture. Br J Pharmacol 96, 480494.
  • Higgins GA, Ballard TM, Huwyler J, Kemp JA & Gill R (2003). Evaluation of the NR2B-selective NMDA receptor antagonist Ro 63-1908 on rodent behaviour: evidence for an involvement of NR2B NMDA receptors in response inhibition. Neuropharmacology 44, 324341.
  • Hille B (1977). The pH-dependent rate of action of local anesthetics on the node of Ranvier. J Gen Physiol 69, 475496.
  • Hiramatsu M, Cho AK & Nabeshima T (1989). Comparison of the behavioural and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine. Eur J Pharmacol 166, 359366.
  • Holtzman SG (1990). Caffeine as a model drug of abuse. Trends Pharmacol Sci 11, 355356.
  • Huettner JE & Bean BP (1988). Block of N-methyl-d-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc Natl Acad Sci U S A 85, 13071311.
  • Jahr CE (1992). High probability opening of NMDA receptor channels by l-glutamate. Science 255, 470472.
  • Janssens N & Lesage AS (2001). Glutamate receptor subunit expression in primary neuronal and secondary glial cultures. J Neurochem 77, 14571474.
  • Johnson JW & Kotermanski SE (2006). Mechanism of action of memantine. Curr Opin Pharmacol 6, 6167.
  • Kashiwagi K, Pahk AJ, Masuko T, Igarashi K & Williams K (1997). Block and modulation of N-methyl-d-aspartate receptors by polyamines and protons: role of amino acid residues in the transmembrane and pore-forming regions of NR1 and NR2 subunits. Mol Pharmacol 52, 701713.
  • Khanna JM, Wu PH, Weiner J & Kalant H (1991). NMDA antagonist inhibits rapid tolerance to ethanol. Brain Res Bull 26, 643645.
  • Kochhar A, Zivin JA & Mazzarella V (1991). Pharmacologic studies of the neuroprotective actions of a glutamate antagonist in ischemia. J Neurotrauma 8, 175186.
  • Koek W, Woods JH & Colpaert FC (1990). N-Methyl-d-aspartate antagonism and phencyclidine-like activity: a drug discrimination analysis. J Pharmacol Exp Ther 253, 10171025.
  • Koh JY & Choi DW (1987). Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Meth 20, 8390.
  • Kornhuber J, Weller M, Schoppmeyer K & Riederer P (1994). Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties. J Neural Transm Suppl 43, 91104.
  • Lee JM, Zipfel GJ & Choi DW (1999). The changing landscape of ischaemic brain injury mechanisms. Nature 399, A7A14.
  • LePage KT, Ishmael JE, Low CM, Traynelis SF & Murray TF (2005). Differential binding properties of [3H]dextrorphan and [3H]MK-801 in heterologously expressed NMDA receptors. Neuropharmacology 49, 116.
  • Li JH, Wang YH, Wolfe BB, Krueger KE, Corsi L, Stocca G & Vicini S (1998). Developmental changes in localization of NMDA receptor subunits in primary cultures of cortical neurons. Eur J Neurosci 10, 17041715.
  • Low CM, Lyuboslavsky P, French A, Le P, Wyatte K, Thiel WH, Marchan EM, Igarashi K, Kashiwagi K, Gernert K, Williams K, Traynelis SF & Zheng F (2003). Molecular determinants of proton-sensitive N-methyl-d-aspartate receptor gating. Mol Pharmacol 63, 12121222.
  • Low CM, Zheng F, Lyuboslavsky P & Traynelis SF (2000). Molecular determinants of coordinated proton and zinc inhibition of N-methyl-d-aspartate NR1/NR2A receptors. Proc Natl Acad Sci U S A 97, 1106211067.
  • MacDonald JF, Bartlett MC, Mody I, Pahapill P, Reynolds JN, Salter MW, Schneiderman JH & Pennefather PS (1991). Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones. J Physiol 432, 483508.
  • MacDonald JF & Nowak LM (1990). Mechanisms of blockade of excitatory amino acid receptor channels. Trends Pharmacol Sci 11, 167172.
  • Meldrum BS, Akbar MT & Chapman AG (1999). Glutamate receptors and transporters in genetic and acquired models of epilepsy. Epilepsy Res 36, 189204.
  • Moffat AC, Osselton MD & Widdop B (2004). Clarke's Analysis of Drugs and Poisons, 3rd edn, vol. 2. Pharmaceutical Press, London .
  • Monaghan DT, Andaloro VJ & Skifter DA (1998). Molecular determinants of NMDA receptor pharmacological diversity. Prog Brain Res 116, 171190.
  • Monaghan DT & Larsen H (1997). NR1 and NR2 subunit contributions to N-methyl-d-aspartate receptor channel blocker pharmacology. J Pharmacol Exp Ther 280, 614620.
  • Mori H, Masaki H, Yamakura T & Mishina M (1992). Identification by mutagenesis of a Mg2+-block site of the NMDA receptor channel. Nature 358, 673675.
  • Mott DD, Doherty JJ, Zhang S, Washburn MS, Fendley MJ, Lyuboslavsky P, Traynelis SF & Dingledine R (1998). Phenylethanolamines inhibit NMDA receptors by enhancing proton inhibition. Nat Neurosci 1, 659667.
  • Mott DD, Erreger K, Banke TG & Traynelis SF (2001). Open probability of homomeric murine 5-HT3A serotonin receptors depends on subunit occupancy. J Physiol 535, 427443.
  • Mozayani A (2003). Phencyclidine – effects on human performance and behavior. Forensic Sci Rev 15, 6174.
  • Myers SJ, Geballe MT, Le P, Lyuboslavsky PN, Dingledine R, Snyder JP & Traynelis SF (2006). pH dependence of phosphono-derivative NMDA receptor antagonists. Abstract Viewer and Itinerary Planner, prog. no. 623.2. Society for Neuroscience 2006 Online.
  • Nedergaard M, Kraig RP, Tanabe J & Pulsinelli WA (1991). Dynamics of interstitial and intracellular pH in evolving brain infarct. Am J Physiol Regul Integr Comp Physiol 260, R581R588.
  • Nicholson KL, Hayes BA & Balster RL (1999). Evaluation of the reinforcing properties and phencyclidine-like discriminative stimulus effects of dextromethorphan and dextrorphan in rats and rhesus monkeys. Psychopharmacology (Berl) 146, 4959.
  • Obrenovitch TP & Urenjak J (1997). Is high extracellular glutamate the key to excitotoxicity in traumatic brain injury? J Neurotrauma 14, 677698.
  • Pahk AJ & Williams K (1997). Influence of extracellular pH on inhibition by ifenprodil at N-methyl-d-aspartate receptors in Xenopus oocytes. Neurosci Lett 225, 2932.
  • Park CK, Nehls DG, Graham DI, Teasdale GM & McCulloch J (1988). The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat. Ann Neurol 24, 543551.
  • Parsons CG, Gruner R, Rozental J, Millar J & Lodge D (1993). Patch clamp studies on the kinetics and selectivity of N-methyl-d-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan). Neuropharmacology 32, 13371350.
  • Raffa RB, Ortegon ME, Robisch DM & Martin GE (1989). In vivo demonstration of the enhancement of MK-801 by l-glutamate. Life Sci 44, 15931599.
  • Sackin H, Nanazashvili M, Palmer LG, Krambis M & Walters DE (2005). Structural locus of the pH gate in the Kir1.1 inward rectifier channel. Biophys J 88, 25972606.
  • Sattler R, Charlton MP, Hafner M & Tymianski M (1998). Distinct influx pathways, not calcium load, determine neuronal vulnerability to calcium neurotoxicity. J Neurochem 71, 23492364.
  • Sattler R & Tymianski M (2001). Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol Neurobiol 24, 107129.
  • Schulte U, Hahn H, Konrad M, Jeck N, Derst C, Wild K, Weidemann S, Ruppersberg JP, Fakler B & Ludwig J (1999). pH gating of ROMK (Kir1.1) channels: control by an Arg-Lys-Arg triad disrupted in antenatal Bartter syndrome. Proc Natl Acad Sci U S A 96, 1529815303.
  • Schwarz W, Palade PT & Hille B (1977). Local anesthetics. Effect of pH on use-dependent block of sodium channels in frog muscle. Biophys J 20, 343368.
  • Slater B, McCormack A, Avdeef A & Comer JE (1994). pH-metric log P. 4. Comparison of partition coefficients determined by HPLC and potentiometric methods to literature values. J Pharm Sci 83, 12801283.
  • Sobolevskii AI & Khodorov BI (2002). Blocker studies of the functional architecture of the NMDA receptor channel. Neurosci Behav Physiol 32, 157171.
  • Sobolevsky AI, Koshelev SG & Khodorov BI (1999). Probing of NMDA channels with fast blockers. J Neurosci 19, 1061110626.
  • Spector R (1988). Transport of amantadine and rimantadine through the blood–brain barrier. J Pharmacol Exp Ther 244, 516519.
  • Stern P, Behe P, Schoepfer R & Colquhoun D (1992). Single-channel conductances of NMDA receptors expressed from cloned cDNAs: comparison with native receptors. Proc Biol Sci 250, 271277.
  • Tang CM, Dichter M & Morad M (1990). Modulation of the N-methyl-d-aspartate channel by extracellular H+. Proc Natl Acad Sci U S A 87, 64456449.
  • Thornberg SA & Saklad SR (1996). A review of NMDA receptors and the phencyclidine model of schizophrenia. Pharmacotherapy 16, 8293.
  • Tombaugh GC & Sapolsky RM (1993). Evolving concepts about the role of acidosis in ischemic neuropathology. J Neurochem 61, 793803.
  • Traynelis SF, Burgess MF, Zheng F, Lyuboslavsky P & Powers JL (1998). Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit. J Neurosci 18, 61636175.
  • Traynelis SF & Cull-Candy SG (1990). Proton inhibition of N-methyl-d-aspartate receptors in cerebellar neurons. Nature 345, 347350.
  • Traynelis SF & Cull-Candy SG (1991). Pharmacological properties and H+ sensitivity of excitatory amino acid receptor channels in rat cerebellar granule neurones. J Physiol 433, 727763.
  • Traynelis SF & Wahl P (1997). Control of rat GluR6 glutamate receptor open probability by protein kinase A and calcineurin. J Physiol 503, 513531.
  • Tricklebank MD, Singh L, Oles RJ, Preston C & Iversen SD (1989). The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur J Pharmacol 167, 127135.
  • Vyklicky L Jr, Vlachova V & Krusek J (1990). The effect of external pH changes on responses to excitatory amino acids in mouse hippocampal neurones. J Physiol 430, 497517.
  • Wang CX & Shuaib A (2005). NMDA/NR2B selective antagonists in the treatment of ischemic brain injury. Curr Drug Targets CNS Neurol Disord 4, 143151.
  • Wiley JL, Li H & Balster RL (1997). Discriminative stimulus effects of site-selective N-methyl-d-aspartate antagonists in NPC 17742-trained rats and squirrel monkeys. Psychopharmacology (Berl) 132, 382388.
  • Willetts J & Balster RL (1988). Phencyclidine-like discriminative stimulus properties of MK-801 in rats. Eur J Pharmacol 146, 167169.
  • Wollmuth LP, Kuner T & Sakmann B (1998). Intracellular Mg2+ interacts with structural determinants of the narrow constriction contributed by the NR1-subunit in the NMDA receptor channel. J Physiol 506, 3352.
  • Wong EH, Kemp JA, Priestley T, Knight AR, Woodruff GN & Iversen LL (1986). The anticonvulsant MK-801 is a potent N-methyl-d-aspartate antagonist. Proc Natl Acad Sci U S A 83, 71047108.
  • Xu H, Yang Z, Cui N, Chanchevalap S, Valesky WW & Jiang C (2000). A single residue contributes to the difference between Kir4.1 and Kir1.1 channels in pH sensitivity, rectification and single channel conductance. J Physiol 528, 267277.
  • Yamakura T, Sakimura K & Shimoji K (2000). N-Methyl-d-aspartate receptor channel block by meperidine is dependent on extracellular pH. Anesth Analg 90, 928932.
  • Yang Z, Xu H, Cui N, Qu Z, Chanchevalap S, Shen W & Jiang C (2000). Biophysical and molecular mechanisms underlying the modulation of heteromeric Kir4.1-Kir5.1 channels by CO2 and pH. J Gen Physiol 116, 3345.
  • Yuan H, Erreger K, Dravid SM & Traynelis SF (2005). Conserved structural and functional control of N-methyl-d-aspartate receptor gating by transmembrane domain M3. J Biol Chem 280, 2970829716.
  • Zarei MM & Dani JA (1995). Structural basis for explaining open-channel blockade of the NMDA receptor. J Neurosci 15, 14461454.
  • Zheng F, Erreger K, Low CM, Banke T, Lee CJ, Conn PJ & Traynelis SF (2001). Allosteric interaction between the amino terminal domain and the ligand binding domain of NR2A. Nat Neurosci 4, 894901.
  • Zhu Y & Auerbach A (2001). Na+ occupancy and Mg2+ block of the N-methyl-d-aspartate receptor channel. J Gen Physiol 117, 275286.